Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reproducible detection of antigen-specific T cells and Tregs via standardized and automated activation-induced marker assay workflows.

Cell reports methods·2026
Same author

Insights into the regulation and signaling landscape of cardiotrophin-like cytokine factor 1 (CLCF1).

Biochimica et biophysica acta. Molecular cell research·2026
Same author

MPN-FIT: a randomized controlled pilot trial of supervised exercise in myeloproliferative neoplasms.

Blood advances·2026
Same author

Severe Scurvy Presenting With Cheek Swelling in a First Nations Child.

The Australasian journal of dermatology·2026
Same author

RIPK3 impacts antibody generation in an induced model of murine lupus through mechanisms other than necroptosis and antigen presentation.

Frontiers in immunology·2025
Same author

Cardiotrophin-like cytokine factor 1 forms a complex with IL12/IL23p40.

Scientific reports·2025
Same journal

Research advances and application prospects of CAR-T therapy in the treatment of age-related diseases.

Frontiers in immunology·2026
Same journal

Machine learning-driven identification and immunohistochemical validation of an integrated immune-inflammatory phenotype for disease-free survival stratification in breast cancer.

Frontiers in immunology·2026
Same journal

Modified treatment protocol for pediatric systemic lupus erythematosus-associated hemophagocytic lymphohistiocytosis with central nervous system involvement: a case report.

Frontiers in immunology·2026
Same journal

Exploratory characterization of IgG1/IgG4 glycosylation and monocyte-derived dendritic cell responses in esophageal squamous cell carcinoma.

Frontiers in immunology·2026
Same journal

JAK-STAT pathway-associated skin diseases: a refined functional framework for inflammatory skin diseases.

Frontiers in immunology·2026
Same journal

Cross-talk among novel programmed cell death pathways: a decisive network in renal ischemia-reperfusion injury.

Frontiers in immunology·2026
See all related articles

Related Experiment Video

Updated: Sep 23, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

16.9K

The NOD Mouse Beyond Autoimmune Diabetes.

Anne-Marie Aubin1,2, Félix Lombard-Vadnais1,3, Roxanne Collin1,2,4

  • 1Immunology-Oncology Division, Maisonneuve-Rosemont Hospital Research Center, Montreal, QC, Canada.

Frontiers in Immunology
|May 16, 2022
PubMed
Summary
This summary is machine-generated.

The Non-Obese Diabetic (NOD) mouse model is crucial for studying autoimmune diabetes and other autoimmune diseases. Genetic modifications reveal the NOD background

Keywords:
NOD micebiliary diseaseneuropathypolyautoimmunitythyroiditis

More Related Videos

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

1.9K
High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.0K

Related Experiment Videos

Last Updated: Sep 23, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

16.9K
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

1.9K
High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

8.0K

Area of Science:

  • Immunology
  • Genetics
  • Endocrinology

Background:

  • Non-Obese Diabetic (NOD) mice spontaneously develop autoimmune diabetes, mirroring human type 1 diabetes.
  • NOD mice, established in 1980, are a key model for autoimmune diabetes research, treatment testing, and understanding disease progression.
  • NOD mice also exhibit polyautoimmunity, including autoimmune thyroiditis and Sjögren's syndrome.

Purpose of the Study:

  • To review the Non-Obese Diabetic (NOD) mouse as a versatile model for studying various autoimmune diseases beyond type 1 diabetes.
  • To explore how genetic manipulation of NOD mice influences autoimmune disease phenotypes.
  • To highlight the utility of NOD mouse variants in dissecting genetic susceptibility and pathophysiology of organ-specific autoimmune diseases.

Main Methods:

  • Review of existing literature on Non-Obese Diabetic (NOD) mouse models and their use in autoimmune disease research.
  • Analysis of genetic modifications in NOD mice and their impact on disease incidence.
  • Examination of commonalities, such as autoantibodies, across autoimmune diseases in NOD variants.

Main Results:

  • Genetic manipulation of NOD mice can confer resistance to diabetes but may increase susceptibility to other autoimmune conditions.
  • The NOD genetic background is inherently prone to autoimmunity, with manipulations potentially redirecting autoimmune responses.
  • Autoantibodies are a common feature in autoimmune diseases observed in NOD mouse variants.

Conclusions:

  • NOD mouse variants are invaluable tools for investigating the pathophysiology and genetic basis of diverse organ-specific autoimmune diseases.
  • Understanding autoimmune disease mechanisms in NOD mice extends beyond diabetes to conditions like thyroiditis and Sjögren's syndrome.
  • The NOD model, including its genetically modified strains, offers broad applications for autoimmune disease research.